Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RHYK2017 in Moderate-to-Severe Asthma
CTR20260519Phase 2Active
- Sponsor
- Renhe Yikang
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxofylline in asthma, sponsored by Renhe Yikang. Started Feb 2026; status: active.
02
Drugs
doxofylline
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20260519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260519.